7/16/2024NMPA Announces Package Insert Revision of Spleen Polypeptide Injection...

7/15/2024CDE Solicits Comments on the Technical Guidelines for IVRT and IVPT St...

7/12/2024CDE Solicits Public Comments on ICH M14 and Its Chinese Translation

7/10/2024MOST Committee Issues the Ethical Guidelines for Human Genome Editing ...

7/9/2024CDE Solicits Comments on the Technical Guidelines for Drug Exposure-Ef...

7/9/2024CDE Solicits Comments on the Technical Guidelines for Clinical Pharmac...

7/8/2024CDE Issues the Technical Guidelines for Pharmaceutical Research on Ora...

7/8/2024NMPA Vice Commissioner Meets Senior Dutch Healthcare Officials.

7/5/2024CDE Solicits Comments on the Technical Guidelines for Non-Clinical Res...

7/5/2024CDE Issues the Technical Guidelines for the Study of Overfilling in Ge...

7/3/2024NMPA Announces Package Insert Revision of Dihydroxypropyl Theophylline...

7/1/2024CDE Issues the Notice on Pilot Implementation of Electronic Drug Regis...

6/27/2024Review of Breakthrough Therapy Drug Development Trends in China

6/27/2024CDE Publicizes the List of Reference Formulations for GQCE Studies (84...

6/26/2024Lawmakers Question FDA's Foreign Drug Inspection Program in India and ...

6/25/2024CDE Solicits Comments on the Draft Technical Guidelines for Clinical P...

6/25/2024CDE Solicits Comments on the Draft Technical Guidelines for Clinical P...

6/25/2024NMPA Solicits Comments on Major Document on Optimizing the Review and ...

6/25/2024NMPA Issues Announcement for Applicability of ICH Guideline Q3C (R9)

6/21/2024Chinas NMPA Meets US Counterpart in First High-level Meeting at FDA HQ...

6/21/2024CDE Solicits Comments on the Technical Guidelines for Non-Clinical Stu...

6/21/2024CDE Issues the Technical Guidelines for Clinical Trial of Viral Infect...

6/19/2024China Made Advances in Pharma Innovation and Quality: NMPA Official

6/18/2024CDE Solicits Comments on the Technical Requirements for the Pharmaceut...

6/17/2024NMPA Announces Package Insert Revision of Cyclophosphamide Adenosine, ...

6/17/2024CDE Solicits Comments on the Guidelines for Clinical Trial Design of N...

6/17/2024CDE Issues the List of Reference Formulations for GQCE Studies (81st B...

6/14/2024CDE Issues the Technical Guidelines for the Assessment of Adverse Even...

6/14/2024CDE Issues the Dossier Requirements for Marketing Registration Applica...

6/14/2024CDE Issues Two Pharmaceutical Change Research Guidelines

Page:1/9 Total number of articles:256: [First][<<] [1] [2] [3] [4] [5] [>>] [End]